Eli Lilly | LLY - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 444.6B 59.91B 2026-06
Abbott USD 158.05B 20.36B 2026-06
ALKERMES USD 8.73B 2.85B 2026-06
Amgen USD 195.44B 5.55B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Baxter International USD 11.01B 2.34B 2026-06
Biogen USD 31.9B 5B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Drreddys Laboratories INR 11.07B 619M 2026-03
Eli Lilly USD 1.13T 260.54B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
J&J USD 611.36B 32.21B 2026-06
Medtronic USD 113.81B 4.51B 2026-09
Merck USD 317.37B 20.27B 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Novo Nordisk A/S DKK 1.4T 373.76B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.24B 566M 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
United Therapeutics USD 23B 2.19B 2026-06
Zoetis USD 30.13B 19.58B 2026-06